Previous close | 94.46 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 17,408 |
Market cap | 5.245B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 30.08 |
EPS (TTM) | 3.14 |
Earnings date | 10 May 2024 |
Forward dividend & yield | 1.10 (1.33%) |
Ex-dividend date | 22 May 2023 |
1y target est | N/A |
Q1 revenue plunged 20.6% year-on-year to 289.6 million euros ($318.79 million), leading to a 40.6% shrink in net profit, which came in at 41.7 million euros, the company said in a note. Revenue from COVID-related business unit dropped 78.5% in the first quarter, in line with an expected 75% decrease year-on year. DiaSorin confirmed its 2023 guidance for the full year, which sees total revenue down 14% on a yearly basis.